Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Go back to Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 26.38 --0 (-0%)
Previous Close $26.38    52 Week High $5.17 
Open $26.38    52 Week Low $0.94 
Day High $26.38    P/E N/A 
Day Low $26.38    EPS $0.00 
Volume 3,168